| Literature DB >> 31809836 |
Alice Shi Ming Li1, Fengling Li2, Mohammad S Eram2, Albina Bolotokova2, Carlo C Dela Seña2, Masoud Vedadi3.
Abstract
Protein arginine methyltransferases (PRMTs) catalyze the transfer of methyl groups to specific arginine residues of their substrates using S-adenosylmethionine as a methyl donor, contributing to regulation of many biological processes including transcription, and DNA damage repair. Dysregulation of PRMT expression is often associated with various diseases including cancers. Different methods have been used to characterize the activities of PRMTs and determine their kinetic parameters including mass spectrometry, radiometric, and antibody-based assays. Here, we present kinetic characterization of PRMTs using a radioactivity-based assay for better comparison along with previously reported values. We also report on full characterization of PRMT9 activity with SAP145 peptide as substrate. We further review the potent, selective and cell-active PRMT inhibitors discovered in recent years to provide a better understanding of available tools to investigate the roles these proteins play in health and disease.Entities:
Keywords: Arginine methylation; Cancer; Chemical probe; PRMT
Mesh:
Substances:
Year: 2019 PMID: 31809836 DOI: 10.1016/j.ymeth.2019.11.017
Source DB: PubMed Journal: Methods ISSN: 1046-2023 Impact factor: 3.608